Cell locomotion is a property, inherent to eukaryotic cells, that is critical to the development, homeostasis, repair and disease processes of multicellular organisms. The molecular mechanisms that regulate cell locomotion are poorly understood by hyaluronan (HA) and one of its cell binding sites, HARC (HA receptor complex) has been implicated in stimulating tumor cell locomotion. It is the long term objective of this proposal to investigate the molecular mechanisms by which HA:HARC interactions promote locomotion and to ultimately determine their role in physiological and disease processes. Our working hypothesis proposes that HA stimulates cell locomotion by activating such messenger mechanisms as protein tyrosine phosphorylation and that this effect is mediated by HARC which contains a hyaluronan binding protein (HABP) and a protein tyrosine kinase that is related to pp60c-src. HA:HARC interactions are predicted to act as an autocrine motility mechanism that regulates tumor cell locomotion. This hypothesis will be addressed by four specific aims: 1. What are the mechanisms by which HA promotes cell locomotion including binding of this polymer to cells, its effects on adhesion and its effect on protein tyrosine phosphorylation? 2. What is the functional role of HABP in mediating the above effects of HA? 3. What is the biochemical and molecular structure of the HABP associated with HARC? 4. What are the properties of the protein kinase associated with HARC? The first specific aim will be addressed by utilizing a fibroblast cell line that contains a promotable EJ-ras construct and that exhibits increased locomotion when the mutant ras oncogene is promoted. This increase is mediated by HA and HABP. Since sensitivity to HA:HABP can be modulated by modifying expression of the mutant ras gene, this model represents a unique opportunity to dissect the molecular mechanisms by which HA promotes tumor cell locomotion. To aid in assessing the role of HABP as a mediator of HA (Specific Aim #2), neutralizing monoclonal antibodies to HABP, that have been developed in the past year, will be used. To ultimately and directly test the working hypothesis and long term objective of defining the physiological role of HA:HARC interactions, it will be essential to characterize HABP and the associated protein kinase as indicated in specific aims 2 and 4. Characterization of HABP will be aided by a panel of monoclonal antibodies that have been prepared against native HABP and a partial cDNA encoding HABP. Because of its serological similarity to pp60c-src, the possibility that the protein tyrosine kinase associated with HARC is pp60c-src will be addressed by following the association of both metabolically-labelled c-src and genetically marked v- src (using temperature sensitive pp60v-src mutants) with HARC. Collectively these experiments will constitute the first critical step towards defining the role of HA:HARC in physiological and disease processes such as tumor progression. Definition of the mechanisms regulating cell locomotion will provide critical knowledge pertinent to both the genesis of tumor progression and other diseases that may lead to clinical application.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051540-02
Application #
3196300
Study Section
Pathology B Study Section (PTHB)
Project Start
1991-02-01
Project End
1994-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Manitoba
Department
Type
DUNS #
207584707
City
Winnipeg
State
MB
Country
Canada
Zip Code
R3 2-N2
Hall, C L; Wang, C; Lange, L A et al. (1994) Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126:575-88
Samuel, S K; Hurta, R A; Spearman, M A et al. (1993) TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 123:749-58
Wright, J A; Turley, E A; Greenberg, A H (1993) Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 4:473-92
Hoare, K; Savani, R C; Wang, C et al. (1993) Identification of hyaluronan binding proteins using a biotinylated hyaluronan probe. Connect Tissue Res 30:117-26
Turley, E A; Austen, L; Moore, D et al. (1993) Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res 207:277-82
Yang, B; Zhang, L; Turley, E A (1993) Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 268:8617-23
Klewes, L; Turley, E A; Prehm, P (1993) The hyaluronate synthase from a eukaryotic cell line. Biochem J 290 ( Pt 3):791-5
Turley, E A; Belch, A J; Poppema, S et al. (1993) Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 81:446-53
Turley, E A (1992) Hyaluronan and cell locomotion. Cancer Metastasis Rev 11:21-30
Hardwick, C; Hoare, K; Owens, R et al. (1992) Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117:1343-50